is yerba mate a glp-1 agonist The Incretin Effect of Maté (Ilex paraguariensis) Partially Dependent on Gut-Mediated Metabolism of Ferulic Acid Does Yerba Mate Release GLP-1?
Description
Always seek personalized medical advice for individual healthcare decisions
Therapeutic strategies for neurodegenerative disorders have commonly targeted individual pathological processes
Encouraging results: Novo Nordisks Wegovy, for example, has shown a 20% reduction in heart attack, stroke, or death from heart disease in recent trials
This leads to an imbalance that may reduce GLP-1 secretion
At treatment initiation, the median BMI was 34.9 kg/m 2 (IQR: 32.038.6) and the median %EWL was 40.6% (IQR: 27.952.7)
I hate it because there is so much promise around them, she said
